---
title: "Opus Genetics, Inc. Stock 12‑Month Price Target Raised to $10.69, Implies 163% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290139972.md"
description: "Opus Genetics, Inc.'s average 12-month price target was raised to $10.69 by 16 analysts, up from $10.59. Based on the June 17 closing price, this implies a 163% upside potential. The consensus rating remains 'Buy' with no Holds or Sells."
datetime: "2026-06-18T04:20:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290139972.md)
  - [en](https://longbridge.com/en/news/290139972.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290139972.md)
generator: "portal-rs"
---

# Opus Genetics, Inc. Stock 12‑Month Price Target Raised to $10.69, Implies 163% Upside

-   According to estimates from 16 analysts, Opus Genetics, Inc. stock's average price target has risen from $10.59 to $10.69, with forecasts ranging from $8 to $16 per share
-   Based on the Jun. 17 closing price, the updated target implies approximately 163% potential upside
-   Consensus rating remains at “Buy” across 16 covering analysts, with 16 Buys, 0 Holds and 0 Sells

Explore more price target data and ratings for Opus Genetics, Inc. on the , and track all previous and future analyst recommendations for Opus Genetics, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [IRD.US](https://longbridge.com/en/quote/IRD.US.md)

## Related News & Research

- [Brokers Set Expectations for Opus Genetics FY2030 Earnings](https://longbridge.com/en/news/295653446.md)
- [Oppenheimer Issues Positive Forecast for Opus Genetics (NASDAQ:IRD) Stock Price](https://longbridge.com/en/news/298500767.md)
- [Apnimed, Inc. reports Q2 results](https://longbridge.com/en/news/298366495.md)
- [TD Waterhouse Canada Inc. Has $184,000 Stock Holdings in AptarGroup, Inc. $ATR](https://longbridge.com/en/news/298802463.md)
- [abrdn Australia Equity Fund NAV at $10.63 as of Sept. 10, 2026](https://longbridge.com/en/news/298745554.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**